LobbyingSam Action lobbying by quarter
Sam Action's latest lobbying report covers Q2 2026, at $70K. The four quarters Q4 2025–Q3 2026 total $210K. Its first report covers Q4 2022; the issues it reports most are Banking and Agriculture.
Sam Action
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $210K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $30K | 2 |
| Q1 2023 | $40K | 2 |
| Q2 2023 | $40K | 2 |
| Q3 2023 | $60K | 2 |
| Q4 2023 | $60K | 2 |
| Q1 2024 | $60K | 2 |
| Q2 2024 | $60K | 2 |
| Q3 2024 | $60K | 2 |
| Q4 2024 | $60K | 2 |
| Q1 2025 | $60K | 2 |
| Q2 2025 | $70K | 2 |
| Q3 2025 | $70K | 2 |
| Q4 2025 | $70K | 2 |
| Q1 2026 | $70K | 2 |
| Q2 2026 | $70K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Banking$226.5K · 15 reports
- Agriculture$219K · 14 reports
- Homeland security$164K · 11 reports
- Budget and appropriations$94K · 7 reports
- Taxation$94K · 7 reports
- Alcohol and drug abuse$37.5K · 3 reports
- Labor, antitrust and workplace$15K · 1 reports
- Roads and highways$15K · 1 reports
- Law enforcement and criminal justice$7,500 · 1 reports
- Medical research and clinical labs$7,500 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- White House Office4 reports
- Drug Enforcement Administration (DEA)1 reports
- Food & Drug Administration (FDA)1 reports
- Justice, Dept of (DOJ)1 reports
- Natl Institutes of Health (NIH)1 reports
- Office of Natl Drug Control Policy (NDCP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSam Action | $880K | 15 quarters |
| Bridge Street Group | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/07for Q2 | Bridge Street Group | Under $5,000 |
| 07/17for Q2 | In-house | $70K |
| 06/01for Q1 | Bridge Street Group | Under $5,000 |
| 05/20for Q1 | In-house | $70K |
| 02/23for Q4 2025 | Bridge Street Group | Under $5,000 |
| 01/16for Q4 2025 | In-house | $70K |
| 25/11/10for Q3 2025 | Bridge Street Group | Under $5,000 |
| 25/11/10for Q2 2025 | Bridge Street Group | Under $5,000 |
| 25/10/09for Q3 2025 | In-house | $70K |
| 25/07/21for Q2 2025 | In-house | $70K |
| 25/05/29for Q1 2025 | Bridge Street Group | Under $5,000 |
| 25/05/06for Q1 2025 | In-house | $60K |
| 25/02/03for Q4 2024 | Bridge Street Group | Under $5,000 |
| 25/01/21for Q4 2024 | In-house | $60K |
| 24/11/04for Q3 2024 | Bridge Street Group | Under $5,000 |
| 24/11/04for Q3 2024 | In-house | $60K |
| 24/07/15for Q2 2024 | In-house | $60K |
| 24/07/10for Q2 2024 | Bridge Street Group | Under $5,000 |
| 24/05/30for Q1 2024 | Bridge Street Group | Under $5,000 |
| 24/04/17for Q1 2024 | In-house | $60K |